Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/IIa trial of oral live attenuated rotavirus vaccine 116E in healthy infants
ISRCTN57452882Phase 2Completed
- Sponsor
- Bharat Biotech
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rotaviral diarrhea comparing 116E rotavirus vaccine with Placebo (2 arms). Primary endpoint: Safety. Started Aug 2006; status: completed.
02
Drugs
116E rotavirus vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on ISRCTN57452882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57452882.